Telerehabilitation Based Exercise Training in Parkinson's Patients
Launched by ISTANBUL UNIVERSITY - CERRAHPASA · Nov 14, 2022
Trial Information
Current as of August 11, 2025
Unknown status
Keywords
ClinConnect Summary
Parkinson disease (PD) is the most common progressive, multisystemic and neurodegenerative disease after Alzheimer disease. Its prevalence increases with age and rises sharply around the age of 65 . The main pathological change is the progressive degeneration of neurons in the substantia nigra pars compacta, one of the nuclei forming then basal ganglia . Currently, pharmacological treatments are used primarily for symptomatic control and provide only short-term benefits before the disease progresses to a severe stage. Physical activity and exercise can provide cost-effective and universally...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Having been diagnosed with PH by a neurologist,
- • Being between 45 and 85 years old,
- • Being between I and III according to the modified Hoehn \& Yahr Staging (29)
- • To have a score of 24 or higher in the Mini Mental State Assessment (30),
- • To be taking their medication regularly.
- Exclusion Criteria:
- • Having an orthopedic disability that will affect balance and mobility,
- • Those with serious chronic diseases that will significantly affect their quality of life (congestive heart failure, myocardial infarction),
- • Severe dyskinesia, cognitive problem that prevents cooperation,
- • Not having internet access with a smart phone or computer,
About Istanbul University Cerrahpasa
Istanbul University - Cerrahpasa is a prestigious academic institution renowned for its commitment to advancing medical research and education. With a focus on innovative clinical trials, the university harnesses cutting-edge methodologies to address pressing health challenges. Its collaborative environment fosters interdisciplinary research, enabling the development of effective therapeutic strategies and enhancing patient care. The institution's dedication to ethical standards and patient safety underscores its reputation as a leader in clinical research within the region and beyond.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Tuğba Argün Pulat
Principal Investigator
Doctor in hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials